Silver Book Fact

Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs therapies; looking for the cause of the disease and continuing to search for environmental and genetic factors; and working to develop new protective drugs that can delay, reverse, or even prevent the disease.

National Institutes of Health, National Institute of Neurological Disorders and Stroke, NIH. Parkinson’s Disease Information Page; 2007. http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm

Reference

Title
Parkinson’s Disease Information Page
Publication Date
2007
Authors
National Institutes of Health, National Institute of Neurological Disorders and Stroke, NIH
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • New Medicines in Development for Parkinson’s Disease in 2018
     
  • An Alzheimer’s disease treatment breakthrough that slowed progression and began to show its effects in 2015, would reduce Medicaid costs for people with the disease by $14 billion in 2020–from…  
  • Impact of Slowed Progression on Severe Stage, Americans Age 65 and Older with Alzheimer’s, 2010-2050  
  • Deep brain stimulation, an electrical signal delivered deep inside the brain, provides significant symptomatic relief for Parkinson’s patients whose medication is no longer effective.  
  • Impact of a 5-Year Delay in Onset on Costs, Americans Age 65 and Older with Alzhemier’s Disease, 2010-2050